Abstract
Intravenous (IV) drug administation is a common procedure requiring venous cannulation. Despite its prevalence, IV therapy has several associated risks, such as infection, phelbitis, hypervolaemia and anaphylaxis. This article provides a brief overview of current clinical guidance on IV therapy and the current challenges in terms of infection control and ensuring patient safety.
| Original language | English |
|---|---|
| Pages (from-to) | 264-268 |
| Number of pages | 5 |
| Journal | British Journal of Healthcare Management |
| Volume | 21 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Clinical guidance
- Infection prevention
- Intravenous therapy
- Patient safety
Fingerprint
Dive into the research topics of 'Intravenous therapy: Guidance and implications for clinical practice'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver